Cidara's $100M PIPE; Pyx­is On­col­o­gy's stock falls on Phase 1 da­ta

Plus, news about ar­genx, Forte Bio­sciences, Ver­ri­ca, Pep2Tan­go Ther­a­peu­tics, Eli Lil­ly, Laek­na, Lin­eage Cell Ther­a­peu­tics and One­Cell Di­ag­nos­tics:

Cidara Ther­a­peu­tics nabs $105M: The im­munother­a­py mak­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER